This project falls within the EPSRC Innovative technologies for regenerative medicine research area, within the Healthcare Technologies Theme.
ndustrial livestock farming is responsible for approximately 14.5 % of global greenhouse gas emissions.
With an increasing number of nations committing to net zero carbon targets by 2050, covering 88 % of total
global emissions, reducing the impact of meat production is critical to meeting these aims. For production
to match the ramping demand, widespread deforestation has been deployed. In the first 6 months of 2022
over 1200 square kilometers of the Brazilian Amazon were cleared, with 36 % of agricultural deforestation
allotted to cattle pastures alone, the largest single utilisation case for the cleared land. This has disastrous
effects on local ecosystems and biodiversity as well as removing one of the largest global carbon sinks.
Additionally, there are significant ethical dilemmas attached to the rearing and slaughter of animals for
human consumption, with over 70 billion animals killed each year.
One of the methods proposed to tackle the environmental and ethical issues associated with meat production is the development of cultured meat. Cultured meat is produced by taking a biopsy from a living
animal and, using tissue engineering techniques, these cells are cultivated to form a product which replicates traditionally available meat options. Ivy Farm are a company at the forefront of this research and
are the industrial partner for this project.
This project proposes that hollow fibre membrane bioreactors are deployed for this application. These
offer a scalable, low-cost platform for cultured meat production when compared to 3D bioprinting alternatives. Additionally, stirred tank bioreactors are used for large volume cell production, but lack the differentiation potential of other bioreactor designs, making them less well suited to replicating the complex
structures and textures of meat.The overarching aim for the project is to design a hollow fibre membrane bioreactor platform which utilises
a wholly edible internal structure and requires minimal downstream processing before it is suitable for
a cultured meat product. Hollow fibre membrane bioreactors are ideally suited to this application as
they facilitate the replication of the in-vivo environment. Hollow fibres serve the role of blood vessels for
1
nutrient and oxygen transport, while providing a scaffold onto which cells can be seeded.
Multiple models of cell stimulation, such as electrical signalling, will be utilised to promote cell differentiation to achieve the desired final structure and texture. The application of these techniques to cultured
meat production is highly novel and will be developed from the ground up alongside Ivy Farm.
The central steps are seen as the evaluation of different materials and manufacturing techniques for the
hollow fibre membranes. These must be compared against a set of parameters that best represent the
performance of genuine animal tissue. This is also a unique challenge to cultured meat, as considerations
of texture and flavour are not required for strictly biomedical applications. Consequently, bioreactor design
and manufacture can be commenced, factoring in stimulation methods to best facilitate differentiation.
Furthermore, there will be a significant mathematical modelling aspect, enabling future design iterations
to optimised. Building on mass transport models developed by collaborators, these will be applied to
the specific conditions within each bioreactor, and validated experimentally. Additionally, this project is
closely linked to the Oxford humanoid bioreactor lab group. Not only does this bring expertise in the field
of in-vitro modelling techniques, but also a close link to the biomedical industry, meaning any potential
applications to novel therapy development can be explored.